Charles River Laboratories Organic revenue (change on a year)
Organic revenue (change on a year) at Charles River Laboratories came to 5.9% for the quarter to 26 Sep 2026, down 0.6 points from a year earlier.
As Charles River Laboratories reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 4 Nov 2026.
By quarter
| Period ending | Organic revenue (change on a year) | Change on a year | Filed |
|---|---|---|---|
| 26 Sep 2026 | 5.9% | down 0.6 points | 4 Nov 2026 |
| 27 Jun 2026 | −1.4% | down 3.7 points | 5 Aug 2026 |
| 28 Mar 2026 | −5.5% | down 3.0 points | 7 May 2026 |
| 27 Dec 2025 | −0.9% | down 0.5 points | 13 Jan 2026 |
| 27 Sep 2025 | 6.5% | up 5.9 points | 5 Nov 2025 |
| 28 Jun 2025 | 2.3% | up 6.2 points | 6 Aug 2025 |
| 29 Mar 2025 | −2.5% | down 5.8 points | 7 May 2025 |
| 28 Dec 2024 | −0.4% | unchanged | 19 Feb 2025 |
| 28 Sep 2024 | 0.6% | — | 6 Nov 2024 |
| 29 Jun 2024 | −3.9% | — | 7 Aug 2024 |
| 30 Mar 2024 | 3.3% | — | 9 May 2024 |
| 30 Dec 2023 | −0.4% | — | 14 Feb 2024 |
Definition
Revenue from this part of the business, as the company names and reports it in its results. Shown as the change on the same period a year earlier, as the company prints it. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.
Other operating KPIs of Charles River Laboratories: Revenue · Remaining performance obligations · Cost of services provided (excluding amortization of intangible assets) revenue · Cost of products sold (excluding amortization of intangible assets) revenue · DSA revenue · RMS revenue · Manufacturing revenue · United States revenue · Europe revenue · Canada revenue · Asia Pacific revenue · financial statements
Every KPI and segment of CRL, in the terminal.
Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.
